Skip to main content

Table 1 Demographic and preoperative data

From: Benefits of ultra-fast-track anesthesia in left ventricular assist device implantation: a retrospective, propensity score matched cohort study of a four-year single center experience

  Unmatched Matched  
  LVAD conv LVAD ultra p-values LVAD match LVAD ultra p-values Patients failed UFTA (n = 2)
n = 30 n = 13 n = 13 n = 13
Age 65.2 ± 8.4 61.1 ± 7.9 0.108 64.1 ± 4.8 61.1 ± 7.9 0.485 63.5 ± 0.5
Female n (%) 6 (20) 2 (15.4) 1.000 1 (7.8) 2 (15.4) 0.500 1(50)
BMI kg/m2 29.5 ± 4.2 26.1 ± 3.1 0.009 26.3 ± 3.0 26.1 ± 3.1 0.735 25.8 ± 1.2
PAD n (%) 7 (23.3) 5 (38.5) 0.460 5 (38.5) 5 (38.5) 1.000 1(50)
creatinine (mg/dl) 1.3 ± 0.2 1.1 ± 0.3 0.032 1.1 ± 0.2 1.1 ± 0.3 0.907 1.1 ± 0.2
GFR mL/min. 65.6 ± 6.4 66.5 ± 6.5 0.673 65.3 ± 6.8 66.5 ± 6.5 0.693 65.5 ± 0.5
Prior HD 2 (6.7) 0 1.000 0 0 - 0
COPD ≤ II n (%) 8 (26.7) 5 (38.5) 0.485 3 (23.1) 5 (38.5) 0.727 1(50)
COPD > II n (%) 4 (6.7) 0 0.297 0 0 - 0
FEV1 % 64.8 ± 7.1 74.4 ± 8.5 0.001 68.5 ± 6.2 74.4 ± 8.5 0.068 69.5 ± 1.5
CVA 2 (6.7) 0 1.000 0 0 - 0
DM n (%) 12 (40) 2 (15.3) 0.163 4 (30.8) 2 (15.3) 0.625 2(100)
Nicotine 20 (66.7) 8 (61.5) 0.742 11 (84.6) 8 (61.5) 0.453 2(100)
DCM n (%) 6 (20) 2 (15.4) 1.000 3 (23.1) 2 (15.4) 1.000 0
ICM n (%) 24 (80) 11 (84.6) 1.000 10 (76.7) 11 (84.6) 1.000 2(100)
CI L/min/m2 2.4 ± 0.7 3.0 ± 1.6 0.651 2.3 ± 1 3.0 ± 1.6 0.251 2.9 ± 1
MPAP mmHg 28.9 ± 11.4 30.6 ± 11.6 0.758 34.5 ± 9.1 30.6 ± 11.6 0.198 30.5 ± 0.5
PCWP mmHg 19.3 ± 9.8 21.3 ± 9.4 0.614 23.8 ± 8.1 21.3 ± 9.4 0.330 24.5 ± 1.5
LVEF % 21.4 ± 6.7 17.7 ± 4.1 0.088 19.1 ± 4.7 17.7 ± 4.1 0.715 20 ± 2
RVEDD1 mm 38.9 ± 5.7 37.4 ± 6.1 0.389 37.5 ± 4.9 37.4 ± 6.1 0.984 38.5 ± 0.5
TAPSE mm 15.7 ± 3.1 14.7 ± 5.6 0.212 15.8 ± 4.1 14.7 ± 5.6 0.552 16.5 ± 0.5
DT n (%) 18 (60) 6 (46.2) 0.509 10 (76.9.6) 6 (46.1) 0.453 0
BTC/BTT n (%) 12 (40) 7 (53.8) 0.509 3 (23.1) 7 (53.8) 0.453 2(100)
EuroSCORE II % 14.1 ± 11.6 13.4 ± 8.1 0.820 14.2 ± 7.8 13.4 ± 8.1 0.786 15.5 ± 0.5
INTERMACS Level n (%):
 Level 3 14 (46.7) 4(30.8) 0.502 2 (15.4) 4 (30.8) 0.431 0
 Level 4 16 (53.3) 9(69.2) 0.502 11 (84.6) 9 (69.2) 0.431 2(100)
  1. Continuous variables are expressed as means ± standard deviation (SD). Categorical variables are expressed as percentages and absolute numbers. Bold writing indicates significance
  2. BMI body-mass-index, BTC bridge to candidacy, BTT bridge to transplantation, CI cardiac index, CPB time cardiopulmonary bypass time (min.), COPD chronic obstructive pulmonary disease, CVA cerebrovascular accident, DCM dilated cardiomyopathy, DM diabetes mellitus, DT destination therapy, EuroSCORE II European System for Cardiac Operative Risk Evaluation II, FEV1% ratio of forced expiratory volume in 1 s (FEV1)/ Forced vital capacity (FVC), GFR glomerular filtration rate (mL/min.), HD hemodialysis, ICM ischemic cardiomyopathy, INTERMACS Interagency Registry for Mechanically Assisted Circulatory Support, LVEF left ventricular ejection fraction, MPAP mean pulmonary artery pressure, PAD peripheral artery disease, PCWP pulmonary capillary wedge pressure (mmHg), RVEDD1 right ventricular end-diastolic basal diameter (mm), TAPSE tricuspid annular plane systolic excursion (mm)